CDER Conversation Explores the Office of Prescription Drug Promotion’s Social Science Research Program - Drug Information Update

If your email program has trouble displaying this email, view it as a web page. CDER Conversation Explores the Office of Prescription Drug Promotion's Social Science Research Program  CDER's Office of Prescription Drug Promotion (OPDP)'s four-person research team investigates issues in direct-to-consumer and health care provider-directed prescription drug promotional communications. The team also provides technical assistance within FDA and to stakeholders, as appropriate, on the design and implementation of studies concerning prescription drug promotion. In this CDER Conversation, we speak to Kathryn (Kit) Aikin, PhD, senior social science analyst and research team lead in OPDP, about this important work.    Learn More This is an automated message delivery system. Replying to this message will not reach DDI staff. If you have comments or questions, please contact us at: 1-888-INFO- FDA (1-888-463-6332) or 301-796-3400 from 8:00 am - 4:30 pm ET Monday - Friday. You can also email us at: druginfo@fda.hhs.gov. Stay Connected with U.S. Food and Drug Administration:         SUBSCRIBER SERVICES: Manage Subscriptions  |  Unsubscribe All  |  Help

This email was sent to ooseims.archieves@blogger.com using GovDelivery Communications Cloud on behalf of: U.S. Food and Drug Administration ·  10903 New Hampshire Ave · Silver Spring, MD ·  20993-0002 ·  1-888-INFO-FDA